Feature GeNeuro pioneering HERVs against neurodegenerative and autoimmune diseases By Len Zehrs Swiss-based GeNeuro (Euronext Paris: CH0308403085 – GNRO) is leveraging the biology of human endogenous retroviruses (HERVs) to stop the causes of neurodegenerative and autoimmune diseases, such as multiple... November 21, 2017